Skip to content

Medable

Enterprise Grade

Medable is a clinical trial platform that unifies eCOA, eConsent, sensors, and device data with a purpose-built AI agent platform for GxP-compliant trial operations.

GDPRHIPAA
30

Overview

Medable is a clinical trial platform for sponsors, sites, and clinical operations teams that combines eCOA, eConsent, sensors, provisioned devices, and BYOD into a unified experience, with a purpose-built AI agent platform for clinical development.

A Platform Built for Clinical Development

Medable's Agent Platform is designed specifically for clinical development, with deep context across GxP compliance, regulatory requirements, and the operational complexity that general-purpose AI platforms are not equipped to navigate. The platform aims to unify clinical systems and workflows, turning data into intelligent, trusted action while reducing manual burden across clinical operations. This is not a generic AI layer applied to trials; it is built for the regulatory and operational realities of clinical research.

Agentified eCOA Across the Trial Lifecycle

Medable's agentified eCOA brings AI-powered workflows to every stage of the trial, from build and deployment to study conduct and data review. The goal is consistent, high-quality data and stronger participant adherence. The platform spans eConsent, sensors, provisioned devices, and BYOD, offering a unified experience that reduces operational complexity across every touchpoint of the trial. By connecting these elements, Medable aims to streamline the participant journey and the data flow from source to review.

Real-World Outcomes

Medable reports several clinical outcomes backed by real-world evidence. eCOA participant adherence exceeded 90% across a 70+ site master protocol, with near-perfect compliance. In Japan, eCOA adherence reached 99%, and first patient in (FPI) was achieved ahead of schedule across a complex regional rollout. Medable Studio reduced trial build time from weeks to one business day. AI-powered translation cut translation timelines by 43%, or half the time to go-live. These figures are company-reported and may vary by study.

Trusted, Traceable, GxP-Ready AI

Medable positions its AI as autonomous where it can be and human-led where it must be, with clinical judgment amplified rather than replaced. Every automated action is logged, explainable, and auditable end-to-end. Critical decisions stay with the study team through human-in-the-loop controls, giving teams full control. Regulatory context is built in from day one, not retrofitted after. This approach supports the traceability and oversight that GxP environments require.

Global Regulatory Compliance and Data Integrity

Medable states that it is built for global regulatory compliance and data integrity, with alignment to HIPAA, GDPR, ISO, FDA 21 CFR Part 11, and ICH E6(R2) GCP. These frameworks matter for sponsors running trials across regions, where data integrity and audit readiness are non-negotiable. The platform's compliance posture is a core part of its value proposition for regulated clinical research.

The 1:1:1 Vision

Medable describes a 1:1:1 vision: one day study start, one day patient enrollment, one year study conduct. The company calls this an ambitious vision and one it is actively building toward. With agentic AI purpose-built for clinical development, Medable says it is making meaningful progress toward timelines the industry once thought were out of reach. This vision is aspirational and not a current guarantee.

What to Consider

Medable's strengths lie in its clinical-specific design, human-in-the-loop controls, and unified data experience. The reported adherence and build-time improvements are notable, though they come from Medable's own evidence and may not generalize to every trial. Pricing is not publicly disclosed, so interested teams should book a demo to learn more. The 1:1:1 vision is a long-term goal, not a current capability. For sponsors and sites evaluating AI in clinical trials, Medable offers a purpose-built option that prioritizes traceability and regulatory context.

Core features

  • Agent Platform purpose-built for clinical development with GxP, regulatory, and operational context
  • Agentified eCOA covering build, deployment, study conduct, and data review
  • Unified experience across eConsent, sensors, provisioned devices, and BYOD
  • Human-in-the-loop controls that keep critical decisions with the study team
  • End-to-end traceability with automated actions logged, explainable, and auditable
  • Compliance alignment with HIPAA, GDPR, ISO, FDA 21 CFR Part 11, and ICH E6(R2) GCP
  • Medable Studio for rapid trial build
  • AI-powered translation workflows

Use cases

  1. 1Running decentralized or hybrid trials across multiple regions and languages
  2. 2Improving eCOA participant adherence and data quality
  3. 3Accelerating trial build and deployment timelines
  4. 4Managing eConsent, sensor, and device data in one place
  5. 5Supporting regulatory-grade audit trails for AI-assisted workflows

Strengths and things to check

Strengths

  • Purpose-built for clinical development rather than adapted from general-purpose AI
  • Human-in-the-loop design preserves clinical judgment and team control
  • Traceable, auditable automation supports GxP and regulatory requirements
  • Unified platform reduces operational complexity across trial touchpoints
  • Reported real-world outcomes include 90%+ eCOA adherence and 99% adherence in Japan

Things to check

  • The 1:1:1 vision (1 day study start, 1 day enrollment, 1 year conduct) is aspirational and not yet achieved
  • Performance claims come from Medable and may not generalize to every trial
  • Pricing and contract terms are not publicly disclosed
  • Adoption may require change management for sites and sponsors

Pricing

Subscription pricing is not listed.

Basic information

Added
Oct 10, 2026
Platforms
Web
Chinese & English
Not marked
API
Marked as supported
Self-hosting
Not marked
Best for
Clinical operations teams, trial sponsors, and research sites seeking a unified, AI-enabled platform for decentralized and hybrid clinical trials.
Information updated
Oct 16, 2026
Website status
Checking
Corrections · Privacy · Data requests?
Contact us

Features, pricing and availability may change. Always verify details on the official website. Maintained by steven · Last updated Oct 16, 2026 →

Related tools

All categories